![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
Here begins the text.
Pmda Pharmaceuticals and Medical Devices Agency
What's newBack number
November 29, 2021Provision of Information regarding Post-marketing Safety updated
- November 29, 2021Information regarding Newly Introduced Electronic Package Inserts posted
- November 29, 2021PMDA Updates (November, 2021) posted
- November 26, 2021PMDA Risk Communication: Fingolimod hydrochloride, etc. posted
- November 24, 2021English Translation of Review Report: Imfinzi (Partial Change Approval)
- November 22, 2021PMDA-ATC with NCC MRCT Webinar 2022
- November 18, 2021ICMRA AMR campaign is in progress, November 18 to 24, 2021.
- November 29, 2021Provision of Information regarding Post-marketing Safety updated
- November 29, 2021Information regarding Newly Introduced Electronic Package Inserts posted
- November 26, 2021PMDA Risk Communication: Fingolimod hydrochloride, etc. posted
- Currently, there is no applicable information.
- Currently, there is no applicable information.
- November 29, 2021PMDA Updates (November, 2021) posted
- November 18, 2021ICMRA AMR campaign is in progress, November 18 to 24, 2021.
